Tag Archives: Amgen
Prolia: Runner Up in Pharm Exec Brand of the Year
This month, Pharm Exec magazine presents its Brand of the Year. Here, Brittany Agro profiles one of the runners-up, Amgen’s osteoporosis treatment, Prolia.
A joint meeting of the European Calcified Tissue Society and the International Bone and Mineral Society, held June 2005 in Geneva, Switzerland, revealed promising developments for more effective treatments in bone heath—specifically geared [...]
Saving Haiti: One Donation at a Time (UPDATED 1/21)
Image by American Red Cross via Flickr
It’s been less than three days since new broke of a massive earthquake in Haiti that all but leveled the struggling country. With thousands dead, a devastated infrastructure, and no emergency plan, countries and businesses around the world have joined in the effort to help the Haitian people with [...]
Posted in News Also tagged Abbott, American Red Cross, Emergency management, Haiti, Health care, Humanitarian aid, Lilly, Red Cross 2 Comments
GSK Signs $120M Deal to Market DMab Overseas
Image via Wikipedia
In an effort to boost its sales force without hiring more sales reps, Amgen announced on Tuesday that it has signed a deal with GlaxoSmithKline to co-market its osteoporosis treatment denosumab—currently pending FDA approval.
GSK will paying $120 million up front (along with royalties) to mutually market denosumab, or DMab, in regions where Amgen [...]
Posted in Deals, News, Technology Also tagged Australia, Canada, denosumab, Dmab, GlaxoSmithKline, Market, Mexico, New Zealand, sales force, U.S. Food and Drug Administration, United States 1 Comment

Biomedical Innovation in Trouble